On Wednesday, June 17, 2015, the Health Resources and Services Administration (“HRSA”) published in the Federal Register a notice of proposed rulemaking entitled “340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties” (“Proposed Rule”). See 80 Fed. Reg. 34,583 (June 17, 2015).
The relatively short Proposed Rule proposes to revise and amend all subparts of 42 C.F.R. Part 10 (“340B Drug Pricing Program”).
Please see full publication below for more information.
